TrialFrontiers in immunology2024

Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study.

Atsushi Fukunaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.